Inventor · disambiguated record
Shimon Amselem
Also filed as: AMSELEM SHIMON
36 granted patents·13 pending applications·2,416 citations·filing 1993–2024
98Inventor score
Files withAZURA OPHTHALMICS LTD15PHARMOS CORP8ADAMA MAKHTESHIM LTD3PAINREFORM LTD3REGENERA PHARMA LTD3
Top patents by PatentIndex Score
49 records- 0198US10688122B2Thiol and disulfide-containing agents for increasing meibomian gland lipid secretionAZURA OPHTHALMICS LTD·Filed 2016·Granted Jun 23, 2020·18 cites·11 claims
- 0298US5961970ASubmicron emulsions as vaccine adjuvantsPHARMOS CORP·Filed 1993·Granted Oct 5, 1999·249 cites·25 claims
- 0398US5662932ASolid fat nanoemulsionsPHARMOS CORP·Filed 1996·Granted Sep 2, 1997·255 cites·39 claims
- 0498US5576016ASolid fat nanoemulsions as drug delivery vehiclesPHARMOS CORP·Filed 1993·Granted Nov 19, 1996·353 cites·54 claims
- 0598US5514670ASubmicron emulsions for delivery of peptidesPHARMOS CORP·Filed 1993·Granted May 7, 1996·474 cites·39 claims
- 0697US12048707B2Compositions and methods for the treatment of meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2023·Granted Jul 30, 2024·3 cites·1 claims
- 0797US11633410B2Compositions and methods for the treatment of meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2021·Granted Apr 25, 2023·6 cites·20 claims
- 0897US11013749B2Compositions and methods for the treatment of meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2020·Granted May 25, 2021·7 cites·20 claims
- 0997US10772899B2Compositions and methods for the treatment of meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2019·Granted Sep 15, 2020·8 cites·30 claims
- 1097US10588915B2Compositions and methods for the treatment of meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2018·Granted Mar 17, 2020·19 cites·14 claims
- 1197US9463201B2Compositions and methods for the treatment of meibomian gland dysfunctionM G THERAPEUTICS LTD·Filed 2015·Granted Oct 11, 2016·28 cites·27 claims
- 1296US5993846ABioadhesive emulsion preparations for enhanced drug deliveryPHARMOS CORP·Filed 1998·Granted Nov 30, 1999·199 cites·20 claims
- 1396US5891469ASolid Coprecipitates for enhanced bioavailability of lipophilic substancesPHARMOS CORP·Filed 1997·Granted Apr 6, 1999·220 cites·22 claims
- 1495US12011457B2Selenium disulfide compositions for use in treating meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2021·Granted Jun 18, 2024·3 cites·27 claims
- 1595US10034887B2Compositions and methods for the treatment of meibomian gland dysfunctionM G THERAPEUTICS LTD·Filed 2016·Granted Jul 31, 2018·14 cites·27 claims
- 1695US5747061ASuspension of loteprednol etabonate for ear, eye, or nose treatmentPHARMOS CORP·Filed 1996·Granted May 5, 1998·149 cites·30 claims
- 1794US11040062B2Selenium disulfide compositions for use in treating meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2017·Granted Jun 22, 2021·8 cites·22 claims
- 1894US5744155ABioadhesive emulsion preparations for enhanced drug deliveryFiled 1993·Granted Apr 28, 1998·172 cites·42 claims
- 1993US5989583ASolid lipid compositions of lipophilic compounds for enhanced oral bioavailabilityPHARMOS LTD·Filed 1997·Granted Nov 23, 1999·201 cites·20 claims
- 2091US12447162B2Compositions and methods for the treatment of meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2024·Granted Oct 21, 2025·0 cites·27 claims
- 2191US12427158B2Compositions and methods for the treatment of meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2024·Granted Sep 30, 2025·0 cites·30 claims
- 2288US12458661B2Selenium disulfide compositions for use in treating meibomian gland dysfunctionAZURA OPHTHALMICS LTD·Filed 2024·Granted Nov 4, 2025·0 cites·29 claims
- 2387US9668974B2Depot formulations of a local anesthetic and methods for preparation thereofPAINREFORM LTD·Filed 2013·Granted Jun 6, 2017·11 cites·18 claims
- 2482US10206876B2Depot formulations of a local anesthetic and methods for preparation thereofPAINREFORM LTD·Filed 2017·Granted Feb 19, 2019·3 cites·24 claims
- 2581US12127559B2Use of cyclodextrins as agrochemical delivery systemADAMA MAKHTESHIM LTD·Filed 2019·Granted Oct 29, 2024·1 cites·24 claims
- 2681US8722105B2Compositions of polymeric myrceneHAZAN ZADIK·Filed 2010·Granted May 13, 2014·5 cites·10 claims
- 2775US6924130B1Enzymatic transesterification or hydrolysis of phospholipids in aqueous mediaYISSUM RES DEV CO·Filed 2000·Granted Aug 2, 2005·4 cites·16 claims
- 2874US9849088B2Depot formulations of a hydrophobic active ingredient and methods for preparation thereofPAINREFORM LTD·Filed 2013·Granted Dec 26, 2017·2 cites·20 claims
- 2974US8476304B2Method for decreasing symptoms of alcohol consumptionMEGIDDO GUR·Filed 2012·Granted Jul 2, 2013·4 cites·5 claims
- 3074US2025057161A1Use of cyclodextrins as agrochemical delivery systemADAMA MAKHTESHIM LTD·Filed 2024·Application pending·0 cites
- 3172US2025049857A1Compositions and methods for treating kidney disease and other diseaseLIVEKIDNEY BIO LTD·Filed 2024·Application pending·0 cites
- 3271US2022226367A1Thiol and disulfide-containing agents for increasing meibomian gland lipid secretionAZURA OPHTHALMICS LTD·Filed 2021·Application pending·0 cites
- 3365US10806763B2Compositions of polymeric myrceneREGENERA PHARMA LTD·Filed 2019·Granted Oct 20, 2020·0 cites·12 claims
- 3465US2023013824A1Compositions for the treatment of hyperkeratosis disordersAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 3564US2020179440A1Thiol and disulfide-containing agents for increasing meibomian gland lipid secretionAZURA OPHTHALMICS LTD·Filed 2020·Application pending·0 cites
- 3662US9655938B2Compositions of polymeric myrceneREGENERA PHARMA LTD·Filed 2014·Granted May 23, 2017·0 cites·11 claims
- 3762US2025381229A1Hydrogel compositions containing cellular productsLIVEKIDNEY BIO LTD·Filed 2023·Application pending·0 cites
- 3862US2024023557A1Copper-based fungicide compositionDE OLIVEIRA SHERON FRANSISCO·Filed 2021·Application pending·0 cites
- 3960US10307449B2Compositions of polymeric myrceneREGENERA PHARMA LTD·Filed 2017·Granted Jun 4, 2019·0 cites·21 claims
- 4058US2010256198A1Method for decreasing symptoms of alcohol consumptionALCOBRA LTD·Filed 2008·Application pending·0 cites
- 4152US2022218877A1Cannabinoid polymeric compositionsCANNASSURE LTD·Filed 2020·Application pending·0 cites
- 4250US11760716B2Drug crystallization under microgravity conditionsSPACEPHARMA R&D ISRAEL LTD·Filed 2019·Granted Sep 19, 2023·0 cites·14 claims
- 4350US2004110827A1High enantiomeric purity dexanabinol for pharmaceutical compositionsFiled 2003·Application pending·0 cites
- 4448US9808446B2Method for decreasing symptoms of alcohol consumptionALCOBRA LTD·Filed 2015·Granted Nov 7, 2017·0 cites·10 claims
- 4546US11484516B2Agents for increasing meibomian gland lipid secretionAZURA OPHTHALMICS LTD·Filed 2018·Granted Nov 1, 2022·0 cites·16 claims
- 4642US2007060636A1High enantiomeric purity dexanabinol for pharmaceutical compositionsAVIV HAIM·Filed 2006·Application pending·0 cites
- 4741US2021022335A1Use of cyclodextrins as agrochemical delivery systemADAMA MAKHTESHIM LTD·Filed 2019·Application pending·0 cites
- 4839US9585893B2Flumazenil complexes, compositions comprising same and uses thereofCOERULEUS LTD·Filed 2013·Granted Mar 7, 2017·0 cites·20 claims
- 4939US2009068143A1Orally effective cannabinoid analogsPHARMOS CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shimon Amselem files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →